Introduction {#sec1-1}
============

In Fanconi anemia (FA) and Down syndrome (DS), chromosomal aberrations\[[@ref1]\] and cancer proneness are hallmark features shared by these two disorders, as well as other manifestations including early aging, immunological dysfunction, and congenital malformations.\[[@ref2]\]

Fanconi anemia (MIM 227650) is a rare autosomal recessive disorder featuring bone marrow failure, proneness to malignancies, and chromosomal instability.\[[@ref3][@ref4]\] FA is diagnosed by detection of excess chromosomal instability induced by diepoxybutane (DEB) or mitomycin C.\[[@ref5][@ref6]\] The high frequency of chromosomal breaks in FA has been related to the increased oxidative damage via the intermediacy of superoxide that stimulates further superoxide production. This long-lasting process may exceed the DNA repair system leading to progressive impairment of bone marrow and predisposing patients to leukemia.\[[@ref7]\]

Down syndrome (MIM 190685) is caused by trisomy 21 and the over-expression of the genes present on the extra chromosome 21. DS is the most common aneuploidy, occurring as frequently as approximately one in every 700 live births.\[[@ref8][@ref9]\] The evidence of increased oxidative stress in DS is strong and includes gene dose overexpression of superoxide dismutase (SOD), increased lipid peroxidation, and increased oxidative DNA damage. Oxidative stress may have a direct role in producing the neuropathology of DS.\[[@ref10]\]

Genome integrity in FA and DS has diagnostic and prognostic importance because of the evident relationship between genome instability and both DNA damage and cancer predisposition.\[[@ref11]\] DNA damage is detected by Comet assay represented by an increase of DNA fragments that have migrated out of the cell nucleus in the form of a characteristic streak similar to the tail of a comet.\[[@ref12]\]

Antioxidant administration plays an important role in improving the disease course by decreasing oxidative stress-associated complications.\[[@ref2][@ref13][@ref14]\]

The aim of the study was to explore the oxidative stress state in children with DS and FA by estimating the levels of antioxidants (malondialdehyde (MDA), total antioxidant capacity and SOD activity) and DNA damage, and to evaluate the effect of antioxidant treatment on these patients.

Subjects and Methods {#sec1-2}
====================

Patients enrolled in the study were selected randomly from patients referred to the outpatient clinic of the Clinical Genetics Department, NRC, Egypt and they were followed-up for 1½ years during 2012--2014. The patients' ages ranged between 2 and 10 years. The study included 32 children clinically diagnosed as FA (group I: 17 patients), DS (group II: 15 patients) in addition to 17 controls (group III) matched for age and sex. An informed consent was signed by the parents. The study was approved by the Ethical Committee of the National Research Centre.

Exclusion criteria {#sec2-1}
------------------

Children (patients or controls) taking antioxidants or multivitamins containing antioxidantsTransplanted FA patients.

All children enrolled in the study were subjected to:

Clinically: Full history takingPedigree constructionThorough clinical examination of all body systems to detect any system abnormalityEssential anthropometric measures\[[@ref15]\]Laboratory investigations at the start of the study:Complete blood count (CBC) for FA patientsCytogenetic study:Conventional cytogenetic study\[[@ref16]\]Induction of chromosomal breakage by the DEB for FA patients to confirm the diagnosis of FA and to determine the degree of the chromosomal breakage before starting the antioxidant therapy\[[@ref17][@ref18]\]Comet assay: DNA damage was evaluated in leukocytes\[[@ref19]\]Estimation of Oxidative stress parameters including:Thiobarbituric acid reactive species (MDA) as a marker of lipid peroxidation\[[@ref20]\]Total antioxidant capacity biomarker\[[@ref21]\]Superoxide dismutase biomarker as an antioxidant enzyme\[[@ref22]\]Antioxidants therapy: Including Vitamin A, E, and C were given to the patients according to the recommended daily allowance for 6 months. Vitamin A was given in a dose of 4000 IU/day, Vitamin E in 10 mg/day, and Vitamin C in 25 mg/dayClinical follow-up every month: All patients were clinically examined every month to assure their compliance to treatment and check for any complaintsRe-evaluation after 6 months of treatment:Clinical re-evaluation and essential anthropometric measurements were done for all patientsLaboratory tests including CBC, evaluation of the DNA damage level was done by DEB test and comet assay and the values of oxidative stress were repeated to evaluate the effect of antioxidant therapy.

Statistical analysis {#sec2-2}
--------------------

Statistical analysis was performed on IBM/PC using statistical computer program Statistical Package for the Social Sciences (SPSS) version 14.0 for windows (SPSS Inc. Chicago, USA). The tests used were descriptive test, Pearson\'s correlation test (correlation coefficient r) to test a positive or negative linear relationship between two variables and simple t- test (*p* - values \< 0.05 were considered significant).

Results {#sec1-3}
=======

Demographic and clinical features of FA patients (group I) are summarized in [Table 1](#T1){ref-type="table"}.

###### 

Clinical data of group I (Fanconi anemia)

![](AMHSR-5-205-g001)

Oxidative stress parameters in FA patients revealed significantly higher MDA levels (*P* \< 0.01) and non significantly lower total antioxidant capacity (TAC) and SOD levels than the controls (r = −0.5 and *P* = 0.02, respectively) denoting the effect of increased oxidative stress. Improvements of the studied oxidative stress parameters were detected after antioxidant administration with significant lowering of MDA levels (*P* \< 0.01) and significant elevation in TAC (*P* \< 0.01) and SOD levels (*P* \< 0.01) \[[Table 2](#T2){ref-type="table"}, [Figure 1](#F1){ref-type="fig"}\].

###### 

Comparison of the clinical manifestations before and after antioxidants intake in the group I (FA)

![](AMHSR-5-205-g002)

![Comparison between malondialdehyde, total antioxidant capacity, and superoxide dismutase mean levels before and after antioxidants therapy in Fanconi anemia patients compared to controls](AMHSR-5-205-g003){#F1}

Fanconi anemia group of patients showed more significantly higher DEB-induced chromosomal breakage (*P* \< 0.01) and more DNA damage (*P* \< 0.01) than controls (*P* \< 0.05). Significant improvements of DEB and DNA damage levels were detected after antioxidant administration \[Figures [2](#F2){ref-type="fig"}-[4](#F4){ref-type="fig"}\].

![Comparison between diepoxybutane and DNA damage before and after antioxidants therapy in the group I (Fanconi anemia)](AMHSR-5-205-g004){#F2}

![(a) Partial metaphase with multiple chromosomal breaks giving triradial shapes of Fanconi anemia patients before starting the treatment. (b) Partial metaphases with decreased chromosomal breaks after treatment](AMHSR-5-205-g005){#F3}

![High power image of comet assay showing, (a) extensive DNA damage. (b) Less DNA damage after treatment](AMHSR-5-205-g006){#F4}

Anthropometric measurements including height, weight, and head circumference were done for all FA patients. Analysis of the measurements compared to controls revealed a significant difference in the body weight (*P* = 0.02), and head circumference (*P* = 0.04). These measurements were repeated after treatment and revealed non significant improvement mainly in weight. After antioxidants intake, the FA patients showed an improvement of red blood cells, hemoglobin and platelets levels (the most significant improvement was in platelets, *P* = 0.02), while no change occurred in white blood cells count.

The second group (patients with DS) comprised of 12 males and three females with a ratio of 4:1. Their ages ranged from 1 to 5 years; mean age was 3 (1.36) years. Positive parental consanguinity was observed in 46.6% of cases. There was no family history in DS patients. Congenital heart defect was found in 46.7% patients. Short stature was detected in 33.3% patients, microcephaly in 33.3% patients, and underweight in 20% patients. The body measurements in DS patients compared to the controls revealed a significant difference in the body weight (*P* \< 0.01), height (*P* \< 0.01), and head circumference (*P* \< 0.01).

Oxidative stress parameters in DS patients revealed significantly higher MDA (*P* \< 0.01) and SOD (*P* = 0.01) levels, and non significantly different in TAC levels compared with controls \[[Figure 5](#F5){ref-type="fig"}\]. A positive correlation was found between SOD and MDA in DS patients (r = 0.53 and *P* = 0.04, respectively). An improvement in oxidative stress parameters occurred after antioxidant administration with lowering of MDA (*P* \< 0.01) and SOD levels (*P* \< 0.05) state the actual *P* value and elevation in TAC levels (*P* \< 0.01) [Figure 5](#F5){ref-type="fig"}. DS patients showed more significantly higher DNA damage (*P* \< 0.01) than controls. DNA damage levels improved (*P* \< 0.01) non significantly after antioxidant administration \[[Table 3](#T3){ref-type="table"}, [Figure 6](#F6){ref-type="fig"}\].

![Comparison between malondialdehyde, total antioxidant capacity, and superoxide dismutase mean levels before and after antioxidants therapy between group II and controls](AMHSR-5-205-g007){#F5}

###### 

Comparison between the clinical manifestations before and after antioxidants intake in group II (down syndrome)

![](AMHSR-5-205-g008)

![Comparison between DNA damage levels before and after antioxidants therapy in group II and controls](AMHSR-5-205-g009){#F6}

Anthropometric measurements including height, weight, and head circumference were done for all DS patients. Analysis of measurements revealed non-significant improvement mainly in weight.

Comparison of the degree of improvement between FA and DS patients after antioxidant intake revealed more improvement in TAC in FA patients (*P* \< 0.01), while a similar degree of improvement occurred in the rest of parameters in both FA and DS patients \[Figures [7](#F7){ref-type="fig"} and [8](#F8){ref-type="fig"}\].

![Differences of oxidative stress parameters in the group I and II before and after taking antioxidants compared with the controls](AMHSR-5-205-g010){#F7}

![Differences of DNA damage in the group I and II before and after taking antioxidants compared with the controls](AMHSR-5-205-g011){#F8}

Discussion {#sec1-4}
==========

Fanconi anemia and DS are two disorders that show chromosomal aberrations and increase cancer proneness. Understanding the relationship between oxidative stress and the manifestations and progression of these diseases is very crucial.

The first group included in this study was diagnosed as FA by DEB test. Positive parental consanguinity was found in 88.2% of the studied cases. Salem *et al.*,\[[@ref23]\] reported a higher incidence of consanguinity (100%) among previously studied Egyptian FA patients. Other similarly affected family members were present in 58.8% of patients. These findings agree with the autosomal recessive inheritance. Online Mendelian Inheritance in Man\[[@ref4]\] reviewed FA and confirmed an autosomal recessive trait in FA.

Anthropometric measurements including height, weight, and head circumference were assessed in the FA group of patients. Analysis of the measurements compared to controls revealed a significant difference in the body weight and head circumference, denoting the effect of FA on the growth of patients. Re-measurements of anthropometry after 6 months of antioxidant supplement showed improvement in most of the patients' body weight. Slight improvement in height and head circumference was also noticed. This improvement could be due to many factors affecting patient\'s growth such as improved appetite, decreased frequencies of chest infections, decreased attacks of bleeding, and good compliance to treatment regimen. Pagano *et al.*,\[[@ref24]\] suggested that antioxidants administration in FA patients aimed at delaying the clinical complications related to oxidative stress. In the present study, oxidative stress parameters in FA patients revealed significantly higher MDA levels than the controls; while SOD was non significantly lower than the controls. On the other hand, there was a non significant difference in TAC levels compared to controls. In addition, a negative correlation was present between SOD and MDA. These findings denote that these patients suffer from the effect of increased oxidative stress. These findings also point to a pro-oxidant state as a key event in the clinical phenotype of FA, providing mechanistic links between oxidative stress and disease progression. Pagano *et al.*,\[[@ref24]\] reported significantly lower SOD activity in FA patients than in the controls. Petrovic *et al.*,\[[@ref25]\] demonstrated the increase of MDA and strongly suggested that FA cells experience increased oxidative stress.

After antioxidants intake, the FA patients showed an improvement of red blood cells, hemoglobin and platelets levels (the most significant improvement was in platelets, while no change occurred in white blood cells count. Improving the oxidative stress status in patients may enhance the hematological cell synthesis and decrease apoptotic process of cells. Ponte *et al.*,\[[@ref26]\] demonstrated that Vitamin E decreases the frequency of chromosomal damage and consequently ameliorating the hematological response.

Fanconi anemia group of patients showed higher DEB-induced chromosomal breakage, and more DNA damage compared to controls. This coincides with the findings of other researches who observed more DNA damage in FA patients than controls.\[[@ref27][@ref28]\]

Pagano *et al.*,\[[@ref29]\] determined a direct association between oxidative DNA damage and chromosomal instability as hallmarks of FA phenotype with a significant increase in oxidative stress. In our study, a non significant correlation was found between oxidative stress and each of DEB-induced chromosomal breakage and DNA damage within FA group. This difference may be due to the smaller sample size of our study or may be due to the variation in the individual capacity of the patients to repair the DNA damage.

In the present study, comparing the results of DEB and DNA damage levels in FA patients before and after antioxidants administration, revealed improvement in the level of DEB induced chromosomal breakage, and DNA damage levels. Moreover, improvement in oxidative stress parameters occurred after antioxidant administration with significant lowering of MDA levels and significant elevation in TAC and SOD levels. Various studies regarding the administration of antioxidants to FA patients showed similar improvements of DNA damage and oxidative stress. Astley *et al.*,\[[@ref30]\] concluded in their study that carotenoids and carotenoid-rich foods can influence DNA damage by counteracting oxidative stress. Similarly, Sacheck *et al.*, and Bernard *et al.*,\[[@ref28][@ref31]\] published lower levels of DNA damage after ingestion of 100 mg Vitamin E/day for 12 weeks.

Pincheira *et al.*,\[[@ref32]\] documented that Vitamin E decreased the frequency of chromosomal damage in FA cells. Collins\[[@ref12]\] investigated the effect of carotene on oxidative DNA damage and found a negative correlation between total serum carotenoids and oxidized pyrimidines. On the contrary, Giovannelli *et al.*,\[[@ref33]\] did not find a correlation between oxidative damaged DNA and antioxidant intake.

Tiano *et al.*,\[[@ref34]\] reviewed the long-term supplementations with repeated ingestions of antioxidants in tablets or foods. They found improved DNA damage assessed by the comet or 8-OHdG measurement. They suggested that combined supplementation of Vitamin C and Vitamin E has been more successful than the single supplementation in showing a protective effect on oxidative damaged DNA.

The second group included 15 patients with trisomy 21. Congenital heart defect was found in 46.7% patients which was in agreement with the results of Weijerman *et al.*,\[[@ref35]\] who found congenital heart defect in 43% of their DS cases.

Anthropometric measurements including height, weight, and head circumference for all DS patients revealed short stature in 33.3% patients, microcephaly in 33.3% patients and underweight in 20% patients. On the other hand, the body measurements in DS patients compared to the controls revealed a significant difference in the body weight, height, and head circumference. These results are in agreement with Chávez *et al.*,\[[@ref36]\] who elucidated that patients with DS showed a significant decrease in height and weight compared to normal individuals. These results are also matching with an interesting study done by Afifi *et al.*\[[@ref37]\]

Oxidative stress parameters in DS patients revealed significantly higher MDA and SOD levels than the controls, while TAC levels were non significantly comparable to the controls. Furthermore, a positive correlation was found between SOD and MDA in DS patients. These findings confirmed that DS patients are suffering from oxidative stress which is partly due to the over-expression of the SOD gene on chromosome 21 in DS patients.\[[@ref10]\] This is in agreement with Garaiová *et al.*,\[[@ref38]\] who detected increased activity of SOD and higher MDA levels than the controls. Campos *et al.*,\[[@ref39]\] proved that TAC was decreased in DS patients. Besides, TAC seems to provide more reliable information about the antioxidant status, at least in DS. In addition, Casado *et al.*,\[[@ref40]\] reported a higher activity of SOD in blood cells of patients with DS compared to controls. They also documented a significant difference in serum concentration of MDA in DS patients.

In the present study, the DS group of patients showed more DNA damage than controls but no correlation was found between DNA damage and oxidative stress parameters. Many studies regarding increased DNA damage in DS are in agreement with the observations of the present study.\[[@ref8][@ref11][@ref41]\]

Musalmah *et al.*, (2006) and Ponte *et al.*,\[[@ref25][@ref42]\] reported an increase in DNA damage in lymphocytes of individuals with DS compared with controls, which was reduced by more than 50% after the addition of Vitamin E to the cell culture. As Vitamin E is a powerful antioxidant, they hypothesized that the increased DNA damage in DS resulted from increased oxidative stress with a protective effect of Vitamin E on chromosomal damage.

An improvement in oxidative stress parameters occurred after antioxidant administration with lowering of MDA and SOD levels and elevation in TAC levels. Furthermore, DNA damage levels in DS patients improved after antioxidants intake. Ciaccio *et al.*, Mustafa *et al.*, Muchová *et al.*,\[[@ref43][@ref44][@ref45]\] Several investigators evaluated the biochemical responses of a nutritional regimen supplemented with vitamins in children with DS and found improvement in the measurements of antioxidant enzymes and reactive oxygen species.

Comparing the degree of improvement of oxidative stress parameters after antioxidants intake between group I and II revealed significant improvement in TAC of group I compared to group II reflecting the more beneficial effect of antioxidants on FA patients. On the other hand, a similar degree of improvement was found in each of MDA and SOD in group I and II. In addition, comparing the degree of improvement of DNA damage after antioxidants intake between group I and II showed no difference. Lloret *et al.* and Ponte *et al.*,\[[@ref2][@ref25]\] published similar results and suggested that oxidative stress increases genomic instability.

Conclusion {#sec1-5}
==========

Oxidative stress and DNA damage play a major role in FA and DS pathogenesis. Improvement in oxidative stress parameters and DNA damage occurred after the intake of antioxidants. Early administration of antioxidants should be recommended as a potential therapy for each of FA and DS patients with the ultimate goal of ameliorating life quality and life expectation.
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